Effects of nomifensine, an inhibitor of endogenous catecholamine re- uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.
Open Access
- 1 April 1977
- journal article
- Published by Wiley
- Vol. 4 (S2) , 191S-197S
- https://doi.org/10.1111/j.1365-2125.1977.tb05752.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Homologous radioimmunoassay for human prolactinInternational Journal of Nuclear Medicine and Biology, 1976
- Bromocriptine treatment of acromegaly.BMJ, 1975
- Effect of nomifensine (Hoe 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomesBiochemical Pharmacology, 1974
- Long-term Treatment of Galactorrhoea and Hypogonadism with BromocriptineBMJ, 1974
- Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatumJournal of Pharmacy and Pharmacology, 1974
- Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3?, 5?-adenosine monophosphate concentrations of rat striatumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Rapid Induction of Prolactin Secretion by 3-Iodo-L-TyrosineNeuroendocrinology, 1974
- Radioimmunoassay of Human Serum ThyrotrophinBMJ, 1971
- Inhibitors of purified beef adrenal tyrosine hydroxylaseBiochemical Pharmacology, 1965
- Immunoassay of Serum Growth Hormone in Acromegalic PatientsBMJ, 1964